Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wong

Showing results (951-960 of 982) with videos related to

Pageof 99
Sort By:
ESMO Real World Data and Digital Oncology|February 6, 2026
Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, multicentre, real-world analysisS Banks, W Hong, K Degeling, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2016
Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18James Lawrence Wynn, Chris S Wilson, Jacek Hawiger, et al.
American Journal of Respiratory and Critical Care Medicine|December 10, 2014
Developing a clinically feasible personalized medicine approach to pediatric septic shockHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.
Critical Care (London, England)|October 3, 2012
The pediatric sepsis biomarker risk modelHector R Wong, Shelia Salisbury, Qiang Xiao, et al.
Critical Care Medicine|June 28, 2011
Validation of a gene expression-based subclassification strategy for pediatric septic shockHector R Wong, Natalie Z Cvijanovich, Geoffrey L Allen, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemiaSampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
Science Translational Medicine|October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic indexLuc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Plos One|November 12, 2014
Corticosteroids and pediatric septic shock outcomes: a risk stratified analysisSarah J Atkinson, Natalie Z Cvijanovich, Neal J Thomas, et al.
Ebiomedicine|February 5, 2016
Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock BiologyHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.
Critical Care Medicine|August 12, 2016
Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock PhenotypeHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.
Pageof 99

Showing results (951-960 of 982) with videos related to

Sort By:
Pageof 99
ESMO Real World Data and Digital Oncology|February 6, 2026
Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, multicentre, real-world analysisS Banks, W Hong, K Degeling, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2016
Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18James Lawrence Wynn, Chris S Wilson, Jacek Hawiger, et al.
American Journal of Respiratory and Critical Care Medicine|December 10, 2014
Developing a clinically feasible personalized medicine approach to pediatric septic shockHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.
Critical Care (London, England)|October 3, 2012
The pediatric sepsis biomarker risk modelHector R Wong, Shelia Salisbury, Qiang Xiao, et al.
Critical Care Medicine|June 28, 2011
Validation of a gene expression-based subclassification strategy for pediatric septic shockHector R Wong, Natalie Z Cvijanovich, Geoffrey L Allen, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemiaSampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
Science Translational Medicine|October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic indexLuc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Plos One|November 12, 2014
Corticosteroids and pediatric septic shock outcomes: a risk stratified analysisSarah J Atkinson, Natalie Z Cvijanovich, Neal J Thomas, et al.
Ebiomedicine|February 5, 2016
Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock BiologyHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.
Critical Care Medicine|August 12, 2016
Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock PhenotypeHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.
Pageof 99